- Joined
- May 5, 2005
- Messages
- 1,534
- Reaction score
- 758
- Points
- 5,091
Advertisement - Members don't see this ad
I don’t understand why PCPs and some psychiatrists are not getting the same scrutiny for overprescribing benzos. Most of the time it’s for a weak indication like generalized anxiety d/o or completely off label for insomnia (I’m also counting long term use of triazolam). Regarding anxiety d/o, no data supports their long term use and the withdrawal symptoms from these addictive drugs can be catastrophic. Yet, when I look on the PMP database, these patients get monthly refills of #60, #90, even #120 tabs. These are usually auto refill requests intiated by the pharmacy to the provider’s office who blindly authorizes them without actually talking to the patient. Most of the time, the patient doesn’t take anywhere close to the amount being prescribed on a monthly basis. They should make these schedule II drugs and force their prescribers to jump through the same hoops as those writing opioids. Pharmacies should also be held accountable as well.
Last edited: